/

Fate Therapeutics

Develops cellular immunotherapies for cancer and autoimmune diseases.

BiotechnologyPharmaceuticals fatetherapeutics.com ↗

Company facts

Founded: 2007
Employees: 161
Headquarters: United States
Type: Public
Listed: NASDAQ: FATE
Subsidiaries: Tfinity Therapeutics, Fate Therapeutics Ltd., Fate Therapeutics B.V.